Your browser doesn't support javascript.
loading
Quantitative evaluation of hepatic and intestinal induction of CYP3A in clinical practice.
Tsutsui, Haruka; Kato, Motohiro; Kuramoto, Shino; Sekiguchi, Nobuo; Shindoh, Hidetoshi; Ozeki, Kazuhisa.
Affiliation
  • Tsutsui H; Research division, Chugai Pharmaceutical Co., Ltd, Gotemba, Shizuoka, Japan.
  • Kato M; Research division, Chugai Pharmaceutical Co., Ltd, Gotemba, Shizuoka, Japan.
  • Kuramoto S; Research division, Chugai Pharmaceutical Co., Ltd, Gotemba, Shizuoka, Japan.
  • Sekiguchi N; Research division, Chugai Pharmaceutical Co., Ltd, Gotemba, Shizuoka, Japan.
  • Shindoh H; Research division, Chugai Pharmaceutical Co., Ltd, Gotemba, Shizuoka, Japan.
  • Ozeki K; Research division, Chugai Pharmaceutical Co., Ltd, Gotemba, Shizuoka, Japan.
Xenobiotica ; 50(8): 875-884, 2020 Aug.
Article in En | MEDLINE | ID: mdl-31885304

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytochrome P-450 CYP3A / Intestines / Liver Type of study: Evaluation_studies / Prognostic_studies Language: En Journal: Xenobiotica Year: 2020 Document type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytochrome P-450 CYP3A / Intestines / Liver Type of study: Evaluation_studies / Prognostic_studies Language: En Journal: Xenobiotica Year: 2020 Document type: Article Affiliation country: Japan